You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
利空疊加 港股疫苗股集體低開 康希諾(6185.HK)跌近4%
格隆匯11月5日丨美股疫苗股集體大跌,拖累港股疫苗股開盤走低,康希諾跌近4%,開拓藥業跌近3%,國藥控股和復星醫藥跌超1%。消息面上,默沙東用於治療新冠病毒感染的莫納皮拉韋(Molnupiravir)獲批在英國上市,或對其他疫苗股形成壓力,美股疫苗股普跌;另外,Moderna因業績不及預期,同時將公司2021年新冠疫苗銷售額指引調低至150-180億美元,昨晚股價大跌近18%。個股方便值得注意的消息是,近日網上流傳一篇瑞銀關於康希諾的研報,研報中闡述公司第三季度存在庫存負面消息及原材料報廢的情況。康希諾昨晚迴應稱,公司確認不存在問題所述的情況。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account